4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-056838
President and CEO sold 43,620 shares at an average $65.05 ($2,837,333)
- President and CEO acquired 43,620 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meeker David P President and CEO | 2025-06-03 | Option exercise 10b5-1 | +43,620 | $4.59 | $200,216 | 245,445 | D |
| Meeker David P President and CEO | 2025-06-03 | Sale 10b5-1 | −43,346 | $65.04 | $2,819,358 | 202,099 | D |
| Meeker David P President and CEO | 2025-06-03 | Sale 10b5-1 | −274 | $65.60 | $17,975 | 201,825 | D |
| Derivatives | |||||||
| Meeker David P President and CEO | 2025-06-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −43,620 | 0 | D | ||
| Open-market sales · 43,620 sh · avg $65.05 · $2,837,333 | |||||||
Loading xslF345X05/tm2517215-1_4seq1.xml…